PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
19531649-4	2009	Our in silico prediction using a reverse-docking approach revealed that LTA(4)H might be a potential target of [6]-gingerol.	gingerol	111-123	leukotriene A4 hydrolase	Homo sapiens	72-79	
19531649-5	2009	We supported our prediction by showing that [6]-gingerol suppresses anchorage-independent cancer cell growth by inhibiting LTA(4)H activity in HCT116 colorectal cancer cells.	gingerol	44-56	leukotriene A4 hydrolase	Homo sapiens	123-130	
19531649-7	2009	Collectively, these findings indicate a crucial role of LTA(4)H in cancer and also support the anticancer efficacy of [6]-gingerol targeting of LTA(4)H for the prevention of colorectal cancer.	gingerol	118-130	leukotriene A4 hydrolase	Homo sapiens	144-151	
28065501-0	2017	Synthesis, docking, cytotoxicity, and LTA4H inhibitory activity of new gingerol derivatives as potential colorectal cancer therapy.	gingerol	71-79	leukotriene A4 hydrolase	Homo sapiens	38-43	
28065501-2	2017	[6]-gingerol, the major bioactive compound of Zingiber officinale, is a potential inhibitor of LTA4H, a highly expressed enzyme in colorectal carcinoma.	gingerol	0-12	leukotriene A4 hydrolase	Homo sapiens	95-100	
28065501-6	2017	Furthermore [6]-gingerol derivatives showed potent LTA4H inhibitory activities in comparison to the universal positive controls (bestatin and 4BSA).	gingerol	16-24	leukotriene A4 hydrolase	Homo sapiens	51-56	
28065501-7	2017	Among the natural gingerols, [10]-gingerol (N3) exhibited the highest LTA4H aminopeptidase and epoxide hydrolase inhibitory activities with IC50; 21.59 and 15.24muM, respectively.	gingerol	29-42	leukotriene A4 hydrolase	Homo sapiens	70-75